bhowe

IDRA Pharma

Long
NASDAQ:IDRA   None
IDRA Pharma with a deeply oversold RSI and a tag of the lower trend line, IDRA looks like a buy.

Related Ideas

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.